Latest News
From the Journals
One in four feel fully recovered following COVID-19 hospitalization
The total number and range of ongoing symptoms at one year was “striking” and emphasizes the “multisystem nature of long COVID.”
From the Journals
Long-term efficacy, safety data for ixekizumab in pediatric psoriasis reported
No new safety findings during weeks 48 to 108 of the trial were reported, including no new cases of inflammatory bowel disease or Candida...
From the Journals
COVID-19 again the third-leading cause of U.S. deaths
The overall number of COVID deaths in 2021 increased around 20% over 2020, when around 384,000 people died from the virus.
Latest News
Three in four U.S. doctors are employed by hospitals, corporate entities: Report
“COVID-19 drove physicians to leave private practice for employment at an even more rapid pace than we’ve seen in recent years.”
Conference Coverage
Wearable sensors deemed reliable for home gait assessment in knee OA
Remote use of wearable gait sensors appears reliable but yields results slightly different from those achieved in the laboratory, researchers from...
From the Journals
Secukinumab’s antipsoriatic effects confirmed in U.S. patient population
Results from a postmarketing trial conducted solely at U.S. centers found similar, albeit lower, responses to secukinumab 300 mg than was noted in...
Conference Coverage
OARSI sets sights on classifying early-stage knee OA
“Early-stage knee OA classification criteria, we believe are critically required,” Gillian Hawker, MD, MSc, said at the OARSI 2022 World Congress...
From the Journals
Myocarditis higher with Moderna COVID vax in young men
Increased risk for myocarditis was seen with both mRNA vaccines in young men, and for the first time suggested a higher risk from vaccination than...
Latest News
Restrictive, vegan-based diet linked to fewer RA symptoms
A small, randomized, crossover study suggests a vegan diet improves joint pain in rheumatoid arthritis, but the findings are unclear.
Feature
Are free lunches back? Docs start seeing drug reps again
“We’re seeing the pandemic evolve the meeting model into a hybrid in-person and virtual.”
News from the FDA/CDC
CDC panel lists reasons to get second COVID booster
One panelist said she was concerned about the potential for “booster fatigue.”